Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 4e-06 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-05 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |